Low-dose (250 mg daily) oral probucol produces a significant antioxidant effect in coronary patients: increases activity of glutathione peroxidase (enzyme utilizing lipoperoxides) and reduces the content of free-radical oxidation products in the blood. Probucol therapy for 7 days before and for 6 months after coronary angioplasty significantly reduces the severity of coronary artery stenosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10517-007-0399-x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!